HSDT
Solana Co
NASDAQ · Healthcare · Medical - Devices · US
$2.24
+0.00%Year over year
Reported trailing growth
- Revenue
- +3992.2%
- EBITDA
- —
- EBIT
- -66.3%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +13.9%
- EBITDA
- +96.5%
- EPS
- +99.7%
Three-year CAGR
- Revenue
- +97.0%
- EBITDA
- —
- EBIT
- -51.9%
- Net income
- —
- EPS
- +57.3%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026